β-cyclodextrin inclusion complex as a potent delivery system for enhanced cytotoxicity of paclitaxel in triple-negative breast cancer cells
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Computational Drug Discovery Methods · Synthesis and biological activity
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (28)
Show source-provided references
1. Manivasagan P, Bharathiraja S, Bui NQ, Lim IG, Oh J (2016) Paclitaxel-loaded chitosan oligosaccharide-stabilized gold nanoparticles as novel agents for drug delivery and photoacoustic imaging of cancer cells. Int J Pharm 511(1):367–37910.1016/j.ijpharm.2016.07.025 ↗
2. Pant A, Negi JS (2018) Novel controlled ionic gelation strategy for chitosan nanoparticles preparation using TPP-β-CD inclusion Complex. Eur J Pharm Sci 112:180–18510.1016/j.ejps.2017.11.020 ↗
3. Zabaleta V, Ponchel G, Salman H, Agüeros M, Vauthier C, Irache JM (2012) Oral administration of paclitaxel with pegylated poly(anhydride) nanoparticles: permeability and pharmacokinetic study. Eur J Pharm Biopharm 81(3):514–52310.1016/j.ejpb.2012.04.001 ↗
4. Kampan NC, Madondo MT, McNally OM, Quinn M, Plebanski M (2015) Paclitaxel and its evolving role in the management of ovarian cancer. Biomed Res Int (1):41307610.1155/2015/413076 ↗
5. Varan G, Varan C, Öztürk SC, Benito JM, Esendağlı G, Bilensoy E (2021) Therapeutic efficacy and biodistribution of paclitaxel-bound amphiphilic cyclodextrin nanoparticles: analyses in 3D tumor culture and tumor-bearing animals in vivo. Nanomaterials 11(2):1–1810.3390/nano11020515 ↗
6. Vemuri SK, Banala RR, Mukherjee S, Uppula P, Gpv S, Gurava GR, Malarvilli T (2019) Novel biosynthesized gold nanoparticles as anti-cancer agents against breast cancer: synthesis, biological evaluation, molecular modelling studies. Mater Sci Eng C 99:417–42910.1016/j.msec.2019.01.123 ↗
7. Meng X-Y, Zhang H-X, Mezei M, Cui M (2012) Molecular docking: a powerful approach for structure-based drug discovery. Curr Comput Aided-Drug Des 7(2):146–15710.2174/157340911795677602 ↗
8. Dordunoo SK, Burt HM (1996) Solubility and stability of taxol: effects of buffers and cyclodextrins. Int J Pharm 133(1–2):191–20110.1016/0378-5173(96)04443-2 ↗
9. Stella VJ, He Q (2008) Cyclodextrins. Toxicol Pathol 36(1):30–4210.1177/0192623307310945 ↗
10. Thapa RK, Kim JO (2023) Nanomedicine-based commercial formulations: current developments and future prospects. J Pharm Investig 53(1):19–3310.1007/s40005-022-00607-6 ↗
11. Tiwari G, Tiwari R, Rai A (2010) Cyclodextrins in delivery systems: applications. J Pharm Bioallied Sci 2(2):7210.4103/0975-7406.67003 ↗
12. Varma MVS, Kaushal AM, Garg A, Garg S (2004) Factors affecting mechanism and kinetics of drug release from matrix-based oral controlled drug delivery systems. Am J Drug Deliv 2(1):43–5710.2165/00137696-200402010-00003 ↗
13. Srihakulung O, Triamchaisri N, Toochinda P, Lawtrakul L (2020) Theoretical study on ferrocenyl hydrazones inclusion complexes with β-cyclodextrin and its three methylated derivatives. J Incl Phenom Macrocycl Chem 98(1–2):79–9110.1007/s10847-020-01011-z ↗
14. Alcaro S, Ventura CA, Paolino D, Battaglia D, Ortuso F (2002) Preparation, characterization, molecular modeling and in vitro activity of paclitaxel-cyclodextrin complexes. Bioorg Med Chem Lett 12(12):1637–164110.1016/S0960-894X(02)00217-2 ↗
15. Ghosh A, Shah M, Minko T, Shah V, Zhang Z (2015) Molecular inclusion complexes of β-cyclodextrin derivatives enhance aqueous solubility and cellular internalization of paclitaxel: preformulation and in vitro assessments. J Pharm Pharmacol 3(2):1–1710.13188/2327-204X.1000016 ↗
16. Ma DL, Chan DSH, Leung CH (2011) Molecular docking for virtual screening of natural product databases. Chem Sci 2(9):1656–166510.1039/C1SC00152C ↗
17. Kitchen DB, Decornez H, Furr JR, Bajorath J (2004) Docking and scoring in virtual screening for drug discovery: methods and applications. Nat Rev Drug Discov 3(11):935–94910.1038/nrd1549 ↗
18. Rajamanikandan S, Sindhu T, Durgapriya D, Anitha JR, Akila S, Gopalakrishnan VK (2011) Molecular docking and QSAR studies on bioactive compounds isolated from marine organisms into the MUC1 oncoprotein. Int J Pharm Pharm Sci 3(SUPPL. 2):168–172
19. Patro NM, Sultana A, Terao K, Nakata D, Jo A, Urano A, Ishida Y, Gorantla RN, Pandit V, Devi K, Rohit S, Grewal BK, Sophia EM, Suresh A, Ekbote VK, Suresh S (2014) Comparison and correlation of in vitro, in vivo and in silico evaluations of alpha, beta and gamma cyclodextrin complexes of curcumin. J Incl Phenom Macrocycl Chem 78(1–4):471–48310.1007/s10847-013-0322-1 ↗
20. Sharma A, Bomzan P, Roy N, Dakua VK, Roy K, Barman A, Dey R, Chhetri A, Dewan R, Dutta A, Kumar A, Roy MN (2023) Exploring the inclusion complex of an anticancer drug with β-cyclodextrin for reducing cytotoxicity toward the normal human cell line by an experimental and computational approach. ACS Omega 8(32):29388–2940010.1021/acsomega.3c02783 ↗
21. Deng S, Liu H, Qi C, Yang A, Li Z (2018) Study on preparation and inclusion behavior of inclusion complexes between β-cyclodextrin derivatives with benzophenone. J Incl Phenom Macrocycl Chem 90(3–4):321–32910.1007/s10847-018-0787-z ↗
22. Ye YJ, Wang Y, Lou KY, Chen YZ, Chen R, Gao F (2015) The preparation, characterization, and pharmacokinetic studies of chitosan nanoparticles loaded with paclitaxel/dimethyl-β-cyclodextrin inclusion complexes. Int J Nanomedicine 10:4309–4319
23. Zarrabi A (2017) Two faces of curcumin; a molecular nutrition and an anti-cancer agent. Int J Nanomater Nanotechnol Nanomedicine 2(1):019–02210.17352/2455-3492.000016 ↗
24. Morais CAS, Lemes Silva B, Denadai ÂML, Lopes JF, De Sousa FB (2017) Structural and thermodynamic investigation of pentoxifylline-cyclodextrin inclusion complex. Chem Phys Lett 682:43–4810.1016/j.cplett.2017.06.003 ↗
25. Silva IS, Feitosa EL, Santos MEP, Silva RM, Rocha MS, da Silva FI, Lima FCA, Costa AMS, Alves PB, de Sousa SAA, Oliveira AP, de Lima SG (2020) Theoretical and experimental investigations on inclusion complex β-cyclodextrin and sulcatone: a cardiovascular activity evaluation. J Braz Chem Soc 31(5):1064–1077
26. Kaur K, Jindal R (2019) Exploring RSM-CCD-optimized chitosan-/gelatin-based hybrid polymer network containing CPM–β-CD inclusion complexes as controlled drug delivery systems. Polym Bull 76(7):3569–359210.1007/s00289-018-2555-z ↗
27. Thongchot S, Jamjuntra P, Prasopsiri J, Thuwajit P, Sawasdee N, Poungvarin N, Warnnissorn M, Sa-Nguanraksa D, O-Charoenrat P, Yenchitsomanus PT, Thuwajit C (2021) Establishment and characterization of novel highly aggressive HER2-positive and triple-negative breast cancer cell lines. Oncol Rep 46(6):1–1310.3892/or.2021.8205 ↗
28. Wang X, Decker CC, Zechner L, Krstin S, Wink M (2019) In vitro wound healing of tumor cells: inhibition of cell migration by selected cytotoxic alkaloids. BMC Pharmacol Toxicol 20(1):1–1210.1186/s40360-018-0284-4 ↗